| Jun 12 2020 |
New York Compounding Pharmacy Settles Fraudulent Billing and Kickback Allegations in Whistleblower Lawsuit |
Tycko & Zavareei LLP |
| Jun 12 2020 |
EPA Announces Request For Comments On ICR For Its P2 Awards Program |
Bergeson & Campbell, P.C. |
| Jun 12 2020 |
Whether Asbestos-Containing Components Were Manufactured by Third Parties No Longer Matters in New Jersey |
Faegre Drinker |
| Jun 12 2020 |
MASBDA Announces Availability Of Grants For Biofuel Entities |
Bergeson & Campbell, P.C. |
| Jun 12 2020 |
China Approves New Food-Contact Materials |
Keller and Heckman LLP |
| Jun 12 2020 |
CBD Brands Commit to Sponsor Observational Research to Evaluate the Impact of Daily CBD Use on the Liver Function of Healthy Adults |
Keller and Heckman LLP |
| Jun 11 2020 |
Even If the Federal Circuit Could Award Attorney Fees for IPR Appeals, § 285 Does Not Permit It Award Fees Incurred During the IPR |
Squire Patton Boggs (US) LLP |
| Jun 11 2020 |
FMCSA Extends Waiver Period For Certain Pre-Employment Drug Tests From 30 to 90 Days |
Jackson Lewis P.C. |
| Jun 11 2020 |
Pennsylvania Governor Issues Updated Guidance for Hospitality Businesses Conducting In-Person Service |
Norris McLaughlin P.A. |
| Jun 11 2020 |
North American Olive Oil Association Submits Citizen Petition to FDA Asking for Standard of Identity for Olive Oil and Olive-Pomace Oil |
Keller and Heckman LLP |
| Jun 10 2020 |
OTC Monograph Reform: Key Takeaways and What Industry Can Expect |
Mintz |
| Jun 10 2020 |
France Intends to Improve the Identification and Assessment of Manufactured Nanomaterials in Food |
Bergeson & Campbell, P.C. |
| Jun 10 2020 |
Fee Shifting Under § 285 Does Not Apply to Conduct Solely Arising in IPR |
McDermott Will & Schulte LLP |
| Jun 10 2020 |
Virginia Enacts “Ban the Box” Legislation for Marijuana Possession Arrests, Charges, and Convictions |
Hunton Andrews Kurth |
| Jun 10 2020 |
Another Federal Judge Dismisses Putative Class Action Over Chocolate-less White Morsels |
Keller and Heckman LLP |
| Jun 9 2020 |
EPA Issues Compliance Advisory Regarding Pesticide Devices Making Claims to Kill the Novel Coronavirus |
Van Ness Feldman LLP |
| Jun 9 2020 |
HRSA Allows 340B Hospitals New Flexibilities to Use 340B Drugs at Offsite Facilities |
McDermott Will & Schulte LLP |
| Jun 9 2020 |
Sugar Association Files Citizen Petition Urging Regulatory Changes and Enforcement Action Related to the Labeling of Sugar Substitutes |
Keller and Heckman LLP |
| Jun 8 2020 |
HRSA Poised to Allow 340B Child Sites to Participate Before Appearing on Cost Report |
Polsinelli PC |
| Jun 8 2020 |
Are Qualified Patients Unqualified Parents? |
University of Missouri School of Law |
| Jun 8 2020 |
COVID-19: 340B Update: HRSA Updates Guidance Granting New HOPD Flexibility |
K&L Gates LLP |
| Jun 8 2020 |
NNI Will Hold Webinar on Advances in Self-Powered Wearable Sensors |
Bergeson & Campbell, P.C. |
| Jun 8 2020 |
FDA Updates Policies to Increase Supply of Ethanol Available for Use in Hand Sanitizers |
Beveridge & Diamond PC |
| Jun 8 2020 |
Senate Finance Committee Holds Hearing on FDA’s Foreign Drug Manufacturing Inspection Process |
Bergeson & Campbell, P.C. |
| Jun 8 2020 |
China Newsletter Spring 2020 Direct Investment & Compliance |
Greenberg Traurig, LLP |
| Jun 8 2020 |
FDA Describes “Substantial Progress” Without Providing Any Specific Details on Planned Regulatory Policy for Products Containing CBD |
Keller and Heckman LLP |
| Jun 7 2020 |
Ninth Circuit Vacates EPA’s Renewal of Conditional Registrations for Lower Volatility Dicamba Formulations |
Bergeson & Campbell, P.C. |
| Jun 5 2020 |
HHS Rule is Good News for Prescription Drug Accumulator Programs |
Hunton Andrews Kurth |
| Jun 5 2020 |
EC Extends Timeline for Finalization of Any Proposal for Revision of FCM Legislation to the End of 2022 |
Keller and Heckman LLP |
| Jun 5 2020 |
Update on FDA’s New Era of Smarter Food Safety Initiative in Light of COVID-19 |
Keller and Heckman LLP |
| Jun 5 2020 |
Workshop On Bioanalysis To Be Held By FDA |
Bergeson & Campbell, P.C. |
| Jun 5 2020 |
New CLARITY-BPA Study Examines Low Dose Effect |
Keller and Heckman LLP |
| Jun 5 2020 |
DOE EERE Announces Workshop On Tools To Accelerate Scaling-Up Of Biobased Fuels |
Bergeson & Campbell, P.C. |
| Jun 4 2020 |
China Publishes Draft Notice on Convergence Matters Related to Transition from MEP Order No. 7 to MEE Order No. 12 |
Bergeson & Campbell, P.C. |
| Jun 4 2020 |
New Massachusetts Safety Standards and Guidelines: Restaurants and Lodgings |
Sherin and Lodgen LLP |
